Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaska Natives
Respiratory syncytial virus (RSV) is the leading viral cause of lower respiratory tract infection including bronchiolitis and pneumonia in infants and children worldwide.
The annual rate of RSV hospitalizations for children less than 2 years of age in the US is 5. 2 per 1,000, but substantially
higher among Native Americans.
There are currently approximately 40 vaccines or antibody products in development designed to prevent RSV infections.
With potential licensure of these products on the horizon, it will be important to establish baseline estimates of the burden of RSV infections in high-risk populations, like Native Americans, and to maintain surveillance post-licensure in order to evaluate impact.
Native Americans are also at higher risk for severe respiratory infections associated with human metapneumovirus (HMPV) and other viruses, which will also be monitored through this system.
The annual rate of RSV hospitalizations for children less than 2 years of age in the US is 5. 2 per 1,000, but substantially
higher among Native Americans.
There are currently approximately 40 vaccines or antibody products in development designed to prevent RSV infections.
With potential licensure of these products on the horizon, it will be important to establish baseline estimates of the burden of RSV infections in high-risk populations, like Native Americans, and to maintain surveillance post-licensure in order to evaluate impact.
Native Americans are also at higher risk for severe respiratory infections associated with human metapneumovirus (HMPV) and other viruses, which will also be monitored through this system.
Related Programs
Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $5,000,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $5,000,000
Who's Eligible
Obtain Full Opportunity Text:
Click here to view the Opportunity
Additional Information of Eligibility:
Additional Information on Eligibility: For-profit institutions are not eligible to apply.
Full Opportunity Web Address:
https://www.fedconnect.net/FedConnect/
Contact:
Agency Email Description:
Grants Policy
Agency Email:
Date Posted:
2018-10-29
Application Due Date:
Archive Date:
2019-03-03
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
